Key result
Juvenile dermatomyositis is linked to ~35-40% lower thigh muscle ATP and phosphocreatine levels versus controls.
Why the study?
Metabolic abnormalities in the muscles of children with juvenile dermatomyositis have not been characterized using noninvasive P-31 magnetic resonance spectroscopy.
Does P-31 MRS identify metabolic abnormalities in the muscles of children with juvenile dermatomyositis?
Observational (n=13)
Does P-31 MRS identify metabolic abnormalities in the muscles of children with juvenile dermatomyositis?
Effect estimate: 35-40% below normal
p-value: p=< 0.003
P-31 MRS can noninvasively detect biochemical defects in energy metabolism in the muscles of children with juvenile dermatomyositis.
MRS may detect muscle metabolic changes in pediatric JDM; leaves open validation as a clinical biomarker.
OBJECTIVE: To characterize metabolic abnormalities in the muscles of children with the juvenile variant of dermatomyositis (JDM) by the use of noninvasive P-31 magnetic resonance spectroscopy (MRS). METHODS: Thirteen patients with JDM (ages 4-16 years) were studied. Biochemical status was evaluated with P-31 MRS by determining the concentrations of the high-energy phosphate compounds, ATP and phosphocreatine (PCr), ratios of inorganic phosphate (Pi) to PCr (Pi:PCr ratio), levels of free cytosolic ADP, and phosphorylation potentials (PPs) during rest, exercise, and recovery. RESULTS: Significant metabolic abnormalities were observed in the thigh muscles of 10 severely affected patients during rest, 2 graded levels of exercise, and recovery. Mean ATP and PCr levels in the muscles of JDM patients were 35-40% below the normal control values (P < 0.003). These data, along with elevated Pi:PCr ratios, higher ADP levels, and abnormal values for PPs, indicated defective oxidative phosphorylation in the mitochondria of diseased JDM muscles. MRS findings were normal in 2 additional patients who had improved with prednisone treatment and in 1 patient who had no muscle weakness (amyopathic variant of JDM). CONCLUSION: JDM patients can be monitored with noninvasive P-31 MRS without sedation. Biochemical defects in energy metabolism are concordant with the weakness and fatigue reported by JDM patients. Quantitative MRS data are useful for evaluating patients and optimizing drug treatment regimens.
No takes yet. Share an insight, caveat, or question.
Park et al. (2000) conducted an observational in Juvenile dermatomyositis (n=13). Juvenile dermatomyositis vs. Normal controls was evaluated on Mean ATP and phosphocreatine (PCr) levels (35-40% below normal, p=< 0.003). Juvenile dermatomyositis was associated with mean ATP and phosphocreatine levels in thigh muscles that were 35-40% below normal control values (P < 0.003).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: